Skip to content

Clinical trials

Phase 2 Panic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Panic Disorder Phase: Phase 2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20073
20082
20111
20162
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HB BioTech, LLC2
New York State Psychiatric Institute2
AbbVie1
Alexza Pharmaceuticals, Inc.1
Beth Israel Medical Center1
Boston University Charles River Campus1
Charite University, Berlin, Germany1
Merck Sharp & Dohme LLC1
Nanjing Medical University1
National Institute on Drug Abuse (NIDA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Panic Disorder15
Anxiety Disorders3
Mental Disorders3
Agoraphobia1
Alcoholism1
Generalized Anxiety Disorder1
Major Depressive Disorder1
Neurologic Manifestations1
Phobia, Social1
Rare Diseases1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.